Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and net income for the fourth quarter of 2024.
Earnings Summary: Highlights of IDEXX’s Q4 2024 report

Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and net income for the fourth quarter of 2024.
Biotechnology company Bio-Techne Corporation (NASDAQ: TECH) on Wednesday announced financial results for the fourth quarter of 2024, reporting a decline in profit.
The IPO market witnessed stronger activity so far this year compared to the corresponding period last year, with a marked increase in
IQVIA Holdings Inc. (NYSE: IQV), a global provider of advanced analytics solutions and clinical research services to the life sciences industry, reported
Quest Diagnostics Inc (NYSE: DGX) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Shawn Bevec -- VP, Investor Relations James E. Davis -- Chairman,
Thermo Fisher Scientific Inc (NYSE: TMO) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Rafael Tejada -- Vice President Investor Relations Marc
IQVIA Holdings Inc (NYSE: IQV) Q4 2022 earnings call dated Feb. 10, 2023 Corporate Participants: Nick Childs -- Senior Vice President - Investor Relations and
Quest Diagnostics Inc (NYSE: DGX) Q4 2022 earnings call dated Feb. 02, 2023 Corporate Participants: Shawn Bevec -- Vice President, Investor Relations Jim Davis -- President,
Quest Diagnostics Incorporated (NYSE: DGX) has announced financial results for the fourth quarter of 2022, reporting a sharp decline in adjusted profit
Thermo Fisher Scientific Inc (NYSE: TMO) Q4 2022 earnings call dated Feb. 01, 2023 Corporate Participants: Rafael Tejada -- Vice President, Investor Relations Marc N.
Biocept, Inc. (NASDAQ: BIOC) Q3 2022 earnings call dated Nov. 28, 2022 Corporate Participants: Jody Cain -- Investor Relations Samuel D. Riccitelli -- Chairman and interim
Agilent Technologies Inc. (NYSE: A) Q4 2022 earnings call dated Nov. 21, 2022 Corporate Participants: Parmeet Ahuja -- Investor Relations Mike McMullen -- President and Chief
IQVIA Holdings Inc. (NYSE: IQV) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Nick Childs -- Senior Vice President, Investor Relations and
Thermo Fisher Scientific Inc. (NYSE: TMO) Q4 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Rafael Tejada -- Vice President, Investor Relations Marc
Quest Diagnostics Inc. (NYSE: DGX) Q3 2022 earnings call dated Oct. 20, 2022 Corporate Participants: Shawn Bevec -- Vice President Investor Relations Stephen H.
Agilent Technologies Inc. (NYSE: A) Q3 2022 earnings call dated Aug. 16, 2022 Corporate Participants: Parmeet Ahuja -- Vice President of Investor
Illumina, Inc. (NASDAQ: ILMN) Q2 2022 earnings call dated Aug. 11, 2022 Corporate Participants: Salli Schwartz -- Vice President of Investor Relations Francis deSouza -- Chief
IQVIA Holdings Inc. (NYSE: IQV) Q2 2022 earnings call dated Jul. 21, 2022 Corporate Participants: Nick Childs -- Senior Vice President, Investor Relations and
Quest Diagnostics Inc. (NYSE: DGX) Q2 2022 earnings call dated Jul. 21, 2022 Corporate Participants: Shawn Bevec -- Vice President of Investor Relations Stephen
Agilent Technologies Inc. (NYSE: A) Q2 2022 earnings call dated May. 24, 2022 Corporate Participants: Parmeet Ahuja -- Vice President of Investor Relations Mike
Illumina Inc. (NASDAQ: ILMN) Q1 2022 earnings call dated May. 05, 2022 Corporate Participants: Salli Schwartz -- Vice President, Investor Relations Sam Samad -- Chief Financial